Advertisement

Krebs und Nährstoffsupplemente

  • Volker Schmiedel
Chapter

Zusammenfassung

Weltweit erkranken jährlich etwa 14 Millionen Menschen neu an Krebs, von denen über 8 Millionen sterben. Damit steht Krebs mit gut 20 % aller Todesfälle nach Herz-Kreislauf-Erkrankungen an zweiter Stelle der Todesstatistik. In epidemiologischen Studien zeigte sich, dass bestimmte Krebsarten eine deutlich verminderte Inzidenz bei einem hohen Konsum bestimmter Nährstoffe und entsprechend hohen Serumkonzentrationen aufweisen. In der Prävention zeigen sich Nährstoffsupplemente allgemein als wirkungslos, in der Therapie von Krebskranken führen sie zu einer verbesserten Lebensqualität und gelten auch in hohen Dosierungen als sicher. Es fehlen große, kontrollierte Interventionsstudien bezüglich präventiver Wirkungen.

Literatur

  1. Albanes D, Heinonen OP, Taylor PR et al.: Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 88(21): 1560–1570 (1996)CrossRefGoogle Scholar
  2. Alfano CM, Imayama I, Neuhouser ML et al.: Fatigue, inflammation, and ω-3 and ω-6 fatty acid intake among breast cancer survivors. J Clin Oncol 30(12): 1280–1287 (2012)CrossRefGoogle Scholar
  3. Bjelakovic G, Gluud LL, Nikolova D et al.: Vitamin D supplementation for prevention of cancer in adults. Cochrane Database Syst Rev (6): CD007469 (2014)Google Scholar
  4. Burgerstein UP, Schurgast H, Zimmermann MG: Burgerstein Handbuch Nährstoffe. 12. Aufl. TRIAS-Verlag, Stuttgart (2012)Google Scholar
  5. Chen GC, Zhang ZL, Wan Z et al.: Circulating 25-hydroxyvitamin D and risk of lung cancer: a dose-response meta-analysis. Cancer Causes Control 26(12): 1719–1728 (2015a)CrossRefGoogle Scholar
  6. Chen GC, Qin LQ, Lu DB et al.: N-3 polyunsaturated fatty acids intake and risk of colorectal cancer: meta-analysis of prospective studies. Cancer Causes Control 26(1): 133–141 (2015b)CrossRefGoogle Scholar
  7. Clarke R, Halsey J, Lewington S et al.: B-vitamin treatment trialists' collaboration: effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med 170(18): 1622–1631 (2010)CrossRefGoogle Scholar
  8. Consolo LZ, Melnikov P, Cônsolo FZ et al.: Zinc supplementation in children and adolescents with acute leukemia. Eur J Clin Nutr 67(10): 1056–1059 (2013)CrossRefGoogle Scholar
  9. Coulter ID, Hardy ML, Morton SC et al.: Antioxidants vitamin C and vitamin E for the prevention and treatment of cancer. J Gen Intern Med 21(7): 735–744 (2006)CrossRefGoogle Scholar
  10. Duffield-Lillico AJ, Reid ME, Rurnbull BW et al.: Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev (2002)Google Scholar
  11. Fritz H, Flower G, Weeks L et al.: Intravenous vitamin C and cancer: A systematic review. Integr Cancer Ther 13(4): 280–300 (2014)CrossRefGoogle Scholar
  12. Gao M, Sun K, Guo M et al.: Fish consumption and n-3 polyunsaturated fatty acids, and risk of hepatocellular carcinoma: systematic review and meta-analysis. Cancer Causes Control 26(3): 367–76 (2015)CrossRefGoogle Scholar
  13. Gumulec J, Masarik M, Adam V et al.: Serum and tissue zinc in epithelial malignancies: a meta-analysis. PLoS One 9(6): e99790 (2014)CrossRefGoogle Scholar
  14. Harris HR, Orsini N, Wolk A: Vitamin C and survival among women with breast cancer: a meta-analysis. Eur J Cance r 50(7): 1223–1231 (2014)CrossRefGoogle Scholar
  15. Hu F, Wu Z, Li G et al.: The plasma level of retinol, vitamins A, C and α-tocopherol could reduce breast cancer risk? A meta-analysis and meta-regression. J Cancer Res Clin Oncol 601–614 (2015)CrossRefGoogle Scholar
  16. Huang RX, Duan YY, Hu JA: Fish intake and risk of liver cancer: a meta-analysis. PLoS One 10(1): e0096102 (2015)CrossRefGoogle Scholar
  17. Keum N, Giovannucci E: Vitamin D supplements and cancer incidence and mortality: a meta-analysis. Br J Cancer 111(5): 976–980 (2014)CrossRefGoogle Scholar
  18. Kong P, Cai Q, Geng Q et al.: Vitamin intake reduces the risk of gastric cancer: meta-analysis and systematic review of randomized and observational studies. PLoS One 9(12): e116060 (2014)CrossRefGoogle Scholar
  19. Lee EH, Myung SK, Jeon YJ et al.: Effects of selenium supplements on cancer prevention: meta-analysis of randomized controlled trials. Nutr Cancer 63(8): 1185–1195 (2011)CrossRefGoogle Scholar
  20. Li P, Xu J, Shi Y et al.: Association between zinc intake and risk of digestive tract cancers: a systematic review and meta-analysis. Clin Nutr 33(3): 415–420 (2014)CrossRefGoogle Scholar
  21. Lim ST, Jeon YW, Suh YJ: Association between alterations in the serum 25-hydroxyvitamin d status during follow-up and breast cancer patient prognosis. Asian Pac J Cancer Prev 16(6): 2507–2513 (2015)CrossRefGoogle Scholar
  22. Lin YS, Lin LC, Lin SW: Effects of zinc supplementation on the survival of patients who received concomitant chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma: follow-up of a double-blind randomized study with subgroup analysis. Laryngoscope 119(7): 1348–1352 (2009)CrossRefGoogle Scholar
  23. Lippman SM, Klein EA, Goodman PJ et al.: Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301(1): 39–51 (2009)CrossRefGoogle Scholar
  24. Luo J, Shen L, Zheng D: Association between vitamin C intake and lung cancer: a dose-response meta-analysis. Sci Rep 4: 6161 (2014)CrossRefGoogle Scholar
  25. Manson JE, Bassuk SS, Lee IM et al.: rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials 33(1): 159–171 (2012)CrossRefGoogle Scholar
  26. Mayland CR, Bennett MI, Allan K et al.: Vitamin C deficiency in cancer patients. Palliat Med 19(1): 17–20 (2005)CrossRefGoogle Scholar
  27. Murphy RA, Mourtzakis M, Chu Q, Baracos VE, Reiman T, Mazurak VC: Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer. Cancer 117(16): 3774–3780 (2011)CrossRefGoogle Scholar
  28. Noel SE, Stoneham AC, Olsen CM et al.: Consumption of omega-3 fatty acids and the risk of skin cancers: a systematic review and meta-analysis. Int J Cancer 135(1): 149–156 (2014)CrossRefGoogle Scholar
  29. PDQ Integrative, Alternative, and Complementary Therapies Editorial Board: High-Dose Vitamin C (PDQ®). National Cancer Institute, Bethesda, MD (2016)Google Scholar
  30. Qiao L, Feng Y: Intakes of heme iron and zinc and colorectal cancer incidence: a meta-analysis of prospective studies. Cancer Causes Control 24(6): 1175–1183 (2013)CrossRefGoogle Scholar
  31. Qin X, Cui Y, Shen L et al.: Folic acid supplementation and cancer risk: a meta-analysis of randomized controlled trials. Int J Cancer 133(5): 1033–1041 (2013)CrossRefGoogle Scholar
  32. Schmiedel V: Quickstart Nährstofftherapie. Hippokrates, Stuttgart (2010)Google Scholar
  33. Schöttker B, Jorde R, Peasey A et al.:Consortium on Health and Ageing: Network of Cohorts in Europe and the United States: Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ 348: g3656 (2014)CrossRefGoogle Scholar
  34. Sieja K, Talerczyk M: Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy. Gynecologic Oncology 93(2): 320–327 (2004)CrossRefGoogle Scholar
  35. Tang JE, Wang RJ, Zhong H et al.: Vitamin A and risk of bladder cancer: a meta-analysis of epidemiological studies. World J Surg Oncol 12: 130 (2014)CrossRefGoogle Scholar
  36. Tumorzentrum München: Nahrungsergänzungsmittel. Nahrungsergänzungsmittel und Krebs. http://www.ernaehrung-krebs-tzm.de/ernaehrung-krebs/nahrungsergaenzungs-mittel.html (2015)
  37. Vinceti M, Dennert G, Crespi CM et al.: Selenium for preventing cancer. Cochrane Database Syst Rev 10(3): CD005195 (2014)Google Scholar
  38. Wang W, Li G, He X et al.: Serum 25-hydroxyvitamin D levels and prognosis in hematological malignancies: a systematic review and meta-analysis. Cell Physiol Biochem 35(5): 1999–2005 (2015)CrossRefGoogle Scholar
  39. Wu Y, Ye Y, Shi Y et al.: Association between vitamin A, retinol intake and blood retinol level and gastric cancer risk: A meta-analysis. Clin Nutr 34(4): 620–626 (2015)CrossRefGoogle Scholar
  40. Xu X, Yu E, Liu L et al.: Dietary intake of vitamins A, C, and E and the risk of colorectal adenoma: a meta-analysis of observational studies. Eur J Cancer Prev (2013)Google Scholar
  41. Yang B, Wang FL, Ren XL, Li D: Biospecimen long-chain N-3 PUFA and risk of colorectal cancer: a meta-analysis of data from 60,627 individuals. PLoS One 9(11): e110574 (2014a)CrossRefGoogle Scholar
  42. Yang B, Ren XL, Fu YQ, Gao JL, Li D: Ratio of n-3/n-6 PUFAs and risk of breast cancer: a meta-analysis of 274135 adult females from 11 independent prospective studies. BMJ Cancer 14 : 105 (2014b)CrossRefGoogle Scholar
  43. Zhang D, Wen X, Wu W et al.: Elevated homocysteine level and folate deficiency associated with increased overall risk of carcinogenesis: meta-analysis of 83 case-control studies involving 35,758 individuals. PLoS One 10(5): e0123423 (2015)CrossRefGoogle Scholar
  44. Zhang YP, Chu RX, Liu H: Vitamin A intake and risk of melanoma: a meta-analysis. PLoS One 9(7): e102527 (2014)CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland 2018

Authors and Affiliations

  • Volker Schmiedel
    • 1
  1. 1.Paramed AGKompetenzzentrum für GanzheitsmedizinBaarDeutschland

Personalised recommendations